These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 24019980)
1. Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas. Kim JR; Moon YJ; Kwon KS; Bae JS; Wagle S; Yu TK; Kim KM; Park HS; Lee JH; Moon WS; Lee H; Chung MJ; Jang KY PLoS One; 2013; 8(9):e74738. PubMed ID: 24019980 [TBL] [Abstract][Full Text] [Related]
2. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Cha EJ; Noh SJ; Kwon KS; Kim CY; Park BH; Park HS; Lee H; Chung MJ; Kang MJ; Lee DG; Moon WS; Jang KY Clin Cancer Res; 2009 Jul; 15(13):4453-9. PubMed ID: 19509139 [TBL] [Abstract][Full Text] [Related]
3. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma. Lee H; Kim KR; Noh SJ; Park HS; Kwon KS; Park BH; Jung SH; Youn HJ; Lee BK; Chung MJ; Koh DH; Moon WS; Jang KY Hum Pathol; 2011 Feb; 42(2):204-13. PubMed ID: 21056897 [TBL] [Abstract][Full Text] [Related]
4. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients. Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803 [TBL] [Abstract][Full Text] [Related]
5. The Expression of SIRT1 and DBC1 in Laryngeal and Hypopharyngeal Carcinomas. Yu XM; Liu Y; Jin T; Liu J; Wang J; Ma C; Pan XL PLoS One; 2013; 8(6):e66975. PubMed ID: 23805287 [TBL] [Abstract][Full Text] [Related]
6. Balance between SIRT1 and DBC1 expression is lost in breast cancer. Sung JY; Kim R; Kim JE; Lee J Cancer Sci; 2010 Jul; 101(7):1738-44. PubMed ID: 20412117 [TBL] [Abstract][Full Text] [Related]
7. SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer. Noguchi A; Kikuchi K; Zheng H; Takahashi H; Miyagi Y; Aoki I; Takano Y Cancer Med; 2014 Dec; 3(6):1553-61. PubMed ID: 25146318 [TBL] [Abstract][Full Text] [Related]
8. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma. Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848 [TBL] [Abstract][Full Text] [Related]
9. SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer. Jung W; Hong KD; Jung WY; Lee E; Shin BK; Kim HK; Kim A; Kim BH Korean J Pathol; 2013 Aug; 47(4):332-9. PubMed ID: 24009628 [TBL] [Abstract][Full Text] [Related]
10. Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma. Kang Y; Jung WY; Lee H; Lee E; Kim A; Kim BH Korean J Pathol; 2012 Dec; 46(6):523-31. PubMed ID: 23323102 [TBL] [Abstract][Full Text] [Related]
11. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage. Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644 [TBL] [Abstract][Full Text] [Related]
12. Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase. Nin V; Escande C; Chini CC; Giri S; Camacho-Pereira J; Matalonga J; Lou Z; Chini EN J Biol Chem; 2012 Jul; 287(28):23489-501. PubMed ID: 22553202 [TBL] [Abstract][Full Text] [Related]
13. Negative regulation of the deacetylase SIRT1 by DBC1. Zhao W; Kruse JP; Tang Y; Jung SY; Qin J; Gu W Nature; 2008 Jan; 451(7178):587-90. PubMed ID: 18235502 [TBL] [Abstract][Full Text] [Related]
14. DBC1 is over-expressed and associated with poor prognosis in colorectal cancer. Zhang Y; Gu Y; Sha S; Kong X; Zhu H; Xu B; Li Y; Wu K Int J Clin Oncol; 2014 Feb; 19(1):106-12. PubMed ID: 23299276 [TBL] [Abstract][Full Text] [Related]
15. Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression. Yu EJ; Kim SH; Kim HJ; Heo K; Ou CY; Stallcup MR; Kim JH Oncogene; 2016 Jun; 35(26):3410-8. PubMed ID: 26477307 [TBL] [Abstract][Full Text] [Related]
16. Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer. Hiraike H; Wada-Hiraike O; Nakagawa S; Saji S; Maeda D; Miyamoto Y; Sone K; Tanikawa M; Oda K; Nakagawa K; Yano T; Fukayama M; Taketani Y Exp Ther Med; 2011 Nov; 2(6):1105-1109. PubMed ID: 22977628 [TBL] [Abstract][Full Text] [Related]
17. A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo. Santos L; Colman L; Contreras P; Chini CC; Carlomagno A; Leyva A; Bresque M; Marmisolle I; Quijano C; Durán R; Irigoín F; Prieto-Echagüe V; Vendelbo MH; Sotelo-Silveira JR; Chini EN; Badano JL; Calliari AJ; Escande C Sci Rep; 2019 Oct; 9(1):14381. PubMed ID: 31591441 [TBL] [Abstract][Full Text] [Related]
18. Identification of DBC1 as a transcriptional repressor for BRCA1. Hiraike H; Wada-Hiraike O; Nakagawa S; Koyama S; Miyamoto Y; Sone K; Tanikawa M; Tsuruga T; Nagasaka K; Matsumoto Y; Oda K; Shoji K; Fukuhara H; Saji S; Nakagawa K; Kato S; Yano T; Taketani Y Br J Cancer; 2010 Mar; 102(6):1061-7. PubMed ID: 20160719 [TBL] [Abstract][Full Text] [Related]
19. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. Escande C; Chini CC; Nin V; Dykhouse KM; Novak CM; Levine J; van Deursen J; Gores GJ; Chen J; Lou Z; Chini EN J Clin Invest; 2010 Feb; 120(2):545-58. PubMed ID: 20071779 [TBL] [Abstract][Full Text] [Related]
20. Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism. Hubbard BP; Loh C; Gomes AP; Li J; Lu Q; Doyle TL; Disch JS; Armour SM; Ellis JL; Vlasuk GP; Sinclair DA Cell Cycle; 2013 Jul; 12(14):2233-40. PubMed ID: 23892437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]